Published • loading... • Updated
Proactive Surveillance Pays Off for Patients with Li-Fraumeni Syndrome
Summary by Inside Precision Medicine
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Proactive Surveillance Pays Off for Patients with Li-Fraumeni Syndrome
Research presented at the annual conference of the European Society of Human Genetics shows that screening people with the rare, inherited cancer predisposition condition Li-Fraumeni syndrome (LFS) brings both medical benefits and substantial healthcare cost reductions. The findings “could help inform future discussions about how surveillance protocols for LFS can be further optimized,” said Marion Rolain, a biomedical researcher and engineer in…
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
